Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking

2017 ◽  
Vol 89 ◽  
pp. 376-385 ◽  
Author(s):  
Ji-Xia Ren ◽  
Zhong Cheng ◽  
Yu-Xin Huang ◽  
Jing-Feng Zhao ◽  
Peng Guo ◽  
...  
2020 ◽  
Author(s):  
Ananta Swargiary ◽  
AKALESH Verma ◽  
Manita Daimari ◽  
Mritunjoy Kumar Roy

The present study investigates the binding affinities of 61 FDA approved drugs against two key proteases of SARS-COV2, 3-chymotrypsin-like protease and papain-like protease. We also investigates the ADMET properties of the top 10 besting binding drugs to understand the drug likeness property.


2007 ◽  
Vol 15 (1) ◽  
pp. 374-380 ◽  
Author(s):  
Jian-Guo Wang ◽  
Yong-Jun Xiao ◽  
Yong-Hong Li ◽  
Yi Ma ◽  
Zheng-Ming Li

2020 ◽  
Author(s):  
Ananta Swargiary ◽  
AKALESH Verma ◽  
Manita Daimari ◽  
Mritunjoy Kumar Roy

The present study investigates the binding affinities of 61 FDA approved drugs against two key proteases of SARS-COV2, 3-chymotrypsin-like protease and papain-like protease. We also investigates the ADMET properties of the top 10 besting binding drugs to understand the drug likeness property.


Sign in / Sign up

Export Citation Format

Share Document